Float Short %

19.74

Margin Of Safety %

Put/Call OI Ratio

0.67

EPS Next Q Diff

0.22

EPS Last/This Y

4.56

EPS This/Next Y

3.87

Price

51.18

Target Price

113.54

Analyst Recom

1.08

Performance Q

-27.1

Relative Volume

0.77

Beta

-3.14

Ticker: SLNO

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	SLNO	46.37	0.44	0.10	112175
2025-11-11	SLNO	48.3	0.44	1.63	112869
2025-11-12	SLNO	47.74	0.47	0.40	118235
2025-11-13	SLNO	47.73	0.47	1.41	122036
2025-11-14	SLNO	49.82	0.47	0.64	122936
2025-11-17	SLNO	47.26	0.47	0.74	123109
2025-11-18	SLNO	48.56	0.46	0.18	126118
2025-11-19	SLNO	47.4	0.46	0.61	127074
2025-11-20	SLNO	44.94	0.46	5.12	126803
2025-11-21	SLNO	44.91	0.38	0.49	120485
2025-11-24	SLNO	45.91	0.62	3.00	60585
2025-11-25	SLNO	49.8	0.62	0.48	60607
2025-11-26	SLNO	49.59	0.63	1.87	62258
2025-12-01	SLNO	49.01	0.66	1.40	65103
2025-12-02	SLNO	48.12	0.65	0.02	65064
2025-12-03	SLNO	50.7	0.66	0.50	64531
2025-12-04	SLNO	52.39	0.67	0.46	64201
2025-12-05	SLNO	51.09	0.66	0.93	63263
2025-12-08	SLNO	51.17	0.67	2.73	63285
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	SLNO	46.31	-	-	-0.66
2025-11-11	SLNO	48.70	-	-	0.06
2025-11-12	SLNO	47.72	-	-	0.06
2025-11-13	SLNO	47.29	-	-	0.18
2025-11-14	SLNO	49.40	-	-	0.18
2025-11-17	SLNO	47.28	-	-	0.18
2025-11-18	SLNO	48.52	-	-	0.15
2025-11-19	SLNO	47.00	-	-	0.15
2025-11-20	SLNO	44.93	-	-	0.15
2025-11-21	SLNO	45.10	-	-	0.19
2025-11-24	SLNO	45.90	-	-	0.19
2025-11-25	SLNO	49.77	-	-	0.18
2025-11-26	SLNO	49.59	-	-	0.18
2025-12-01	SLNO	49.02	-	-	0.18
2025-12-02	SLNO	48.12	-	-	0.18
2025-12-03	SLNO	50.72	-	-	0.18
2025-12-04	SLNO	52.66	-	-	0.18
2025-12-05	SLNO	51.37	-	-	0.18
2025-12-08	SLNO	51.18	-	-	0.18
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	SLNO	-0.06	14.77	18.14
2025-11-11	SLNO	-0.06	14.77	18.14
2025-11-12	SLNO	-0.06	14.77	18.25
2025-11-13	SLNO	-0.06	14.77	18.25
2025-11-14	SLNO	-0.06	14.77	17.91
2025-11-17	SLNO	-0.06	11.55	17.91
2025-11-18	SLNO	-0.06	11.55	17.91
2025-11-19	SLNO	-0.06	11.55	17.91
2025-11-20	SLNO	-0.06	11.55	17.91
2025-11-21	SLNO	-0.06	11.55	17.91
2025-11-24	SLNO	-0.06	19.10	17.22
2025-11-25	SLNO	-0.09	19.10	17.23
2025-11-26	SLNO	-0.09	19.10	19.76
2025-12-01	SLNO	-0.09	19.14	19.74
2025-12-02	SLNO	-0.09	19.14	19.74
2025-12-03	SLNO	-0.09	19.14	19.74
2025-12-04	SLNO	-0.09	19.14	19.74
2025-12-05	SLNO	-0.09	19.14	19.74
2025-12-08	SLNO	-0.09	19.10	19.74
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.47

Avg. EPS Est. Current Quarter

0.61

Avg. EPS Est. Next Quarter

0.69

Insider Transactions

-0.09

Institutional Transactions

19.1

Beta

-3.14

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

43.3

Max Drawdown 5-Year %

-98.2

Target Price

113.54

P/E

Forward P/E

12.61

PEG

P/S

27.86

P/B

5.55

P/Free Cash Flow

EPS

-1.84

Average EPS Est. Cur. Y

0.18

EPS Next Y. (Est.)

4.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-79.5

Relative Volume

0.77

Return on Equity vs Sector %

-42.7

Return on Equity vs Industry %

-27.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.85

EBIT Estimation

Soleno Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 152

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.

stock quote shares SLNO – Soleno Therapeutics Inc Stock Price stock today

news today SLNO – Soleno Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch SLNO – Soleno Therapeutics Inc yahoo finance google finance

stock history SLNO – Soleno Therapeutics Inc invest stock market

stock prices SLNO premarket after hours

ticker SLNO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: SLNO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y